静态负荷作为一个短期的预测和预测标记.
Ana M Gómez García1,2,3, Angel Jesús Arias Arias2, Francisco López Muñoz2,3
1Internal Medicine Unit, Hospital Universitario HM Madrid, Madrid, Spain.
概括
静态负荷,衡量身体因压力的压力,有效预测严重的COVID-19结果,包括长时间住院和死亡率. 这种易于获得的标志物为患者提供了早期,具有成本效益的疾病预后.
科学领域:
- 生物医学科学 生物医学科学
- 临床研究是临床研究.
- 生理学 生理学 生理学
背景情况:
- 静态负荷量化了慢性压力的累积生理应变.
- 偏静电负载的增加与不良健康结果和死亡率的增加有关.
- 它是衡量身体对压力因素的适应能力的指标.
研究的目的:
- 评估全静电负荷作为住院COVID-19患者的预后工具.
- 评估全静态负载和疾病严重程度之间的相关性,包括住院时间,ICU入院和死亡率.
- 为了确定全静电负荷是否可以预测COVID-19之外的患者结果.
主要方法:
- 在住院COVID-19患者中分析临床和实验室参数.
- 基于已确定的生物标志物的静态负荷计算.
- 统计分析以将静态负载与临床结果相关联,例如住院时间,ICU日数和死亡率.
主要成果:
- 静态负荷显著预测了长时间住院和增加ICU日数.
- 增加的静态负荷是COVID-19患者死亡率的强有力的预测因素.
- 这些发现突出了静态负荷在测量COVID-19进展期间生物失调的有效性.
结论:
- 静态负荷对于住院患者来说是一个有价值的,易于获得的预后标记.
- 它提供了早期的,具有成本效益的疾病严重程度和潜在结果的指标.
- 这种标志物显示出预测各种严重疾病的预后的前景,不仅限于COVID-19.
更多相关视频
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.4K
09:00High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
15.8K
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
96
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
96
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
56
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
56
